NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









NeuralTeks

NeuralTeks

Private
Neuilly-sur-SeineEnterprise Softwarehttps://neuralteks.com/

Last Round

Seed

Jan 29, 2025

Est. Valuation

$3M

Total Funding Raised

$240,000

Company Overview

NeuralTeks is a healthtech company that develops an AI-driven multimodal platform for laboratory image analysis to enhance microbiological studies.

Sector

Enterprise Software

Verticals

Workflow Automation, E-commerce

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

custom software developmentstaff augmentationIT consultingsoftware outsourcingdev shopmicrobiological diagnosticsAI-driven diagnosticsautomated vision analysisdigital transformationmobile app developmentweb developmentnearshore developmenttechnical staffingSaaSlab automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeuralTeks Comps

Public and private peers based on sector, stage, and business model.

NeuralTeks comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NeuralTeks Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 29, 2025
AcceleratorNov 6, 2024
AcceleratorSep 9, 2024

Key People

Founding team and executive leadership

Souheil Hanoune

Co-Founder and CTO

Founding Team

Mehdi Nasreddine-Royer

Co-Founder & CEO

Founding Team

NeuralTeks Investors

Notable investors and investment history

NeuralTeks investors
InvestorRounds
Paris Biotech SantéSeed
TechstarsSeed, Accelerator

NeuralTeks Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NeuralTeks Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NeuralTeks's valuation, stock price, and market status.

Firmographic Details

HeadquartersNeuilly-sur-Seine
Employee Range5
Year Founded2024
Last FundingJan 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.